EQUILLIUM, INC. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
EQUILLIUM, INC. (EQ) had Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations of $57.16 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations · last filed 2026-08-13
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $57.16M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $61.32M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $30.28M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $33.12M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations as first filed |
|---|---|---|
| 2026-06-30 | $57.16M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $61.32M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $30.28M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $33.12M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $11.49M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $14.50M 10-Q · filed 2026-05-13 | |
| 2024-12-31 | $18.09M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $15.45M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $11.06M 10-Q · filed 2025-08-14 | |
| 2024-03-31 | $11.57M 10-Q · filed 2025-05-14 | |
| 2023-12-31 | $23.22M 10-K · filed 2026-03-25 | |
| 2023-09-30 | $34.38M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $25.62M 10-Q · filed 2024-08-08 | |
| 2023-03-31 | $24.50M 10-Q · filed 2024-05-09 | |
| 2022-12-31 | $59.11M 10-K · filed 2025-03-27 | |
| 2022-09-30 | $25.73M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $23.81M 10-Q · filed 2023-08-09 | |
| 2022-03-31 | $26.24M 10-Q · filed 2023-05-11 | |
| 2021-12-31 | $50.37M 10-K · filed 2024-03-25 | |
| 2021-09-30 | $77.16M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $73.53M 10-Q · filed 2022-08-15 | |
| 2021-03-31 | $50.86M 10-Q · filed 2022-05-12 | |
| 2020-12-31 | $23.98M 10-K · filed 2023-03-23 | |
| 2020-09-30 | $49.25M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $24.08M 10-Q · filed 2021-08-10 | |
| 2020-03-31 | $20.61M 10-Q · filed 2021-05-13 | |
| 2019-12-31 | $13.22M 10-K · filed 2022-03-23 | |
| 2019-09-30 | $27.66M 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $22.66M 10-Q · filed 2020-08-12 | |
| 2019-03-31 | $21.39M 10-Q · filed 2020-05-13 | |
| 2018-12-31 | $28.51M 10-K · filed 2021-03-24 | $28.51M 10-Q · filed 2019-05-13 |
| 2018-09-30 | $4.98M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $6.63M 10-Q · filed 2019-08-12 | |
| 2018-03-31 | $6.21M 10-Q · filed 2019-05-13 | |
| 2017-12-31 | $7.10M 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |